tirzepatide surmount 5 Presented at ECO 2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial Tirzepatide superior to Semaglutide- SURMOUNT-5

Understanding what to expect, when to worry, and how to manage symptoms keeps you on track instead of abandoning your protocol out of frustration or fear

Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions

4.2 Epilepsy and alcoholism 4.2.1 New-onset epilepsy and alcoholism Acute symptomatic seizures were attributed to acute alcoholism in 2.9% (3/102) of the adults who presented for the first time in the emergency department in five Latin American countries (99)

Recently, GLP-1/GIP/Glucagon receptor triagonists have been in development and clinical trials

The medicine affects your system in many ways, but the main two factors that drive weight loss are hunger and blood sugar regulation

The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis